The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.
Related Posts
FTX sues crypto exchange Binance and its former CEO Zhao for $1.8 billion
The litigation marks the latest escalation of tensions between two of the biggest names in crypto, after the meteoric collapse of FTX rocked the market.
Mark Cuban says ‘It’s the Harris campaign vs. Elon,’ not Trump
Mark Cuban discussed Elon Musk and Donald Trump while advocating for Kamala Harris as a more pro-business presidential candidate.
Larry Ellison wraps up banner year as Oracle’s stock rallies most since dot-com boom
Oracle shares have jumped 63% in 2024 and are headed for their best year since 1999, adding over $75 billion to Larry Ellison’s net worth.